ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 19 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $900 | -3.7% | 989 | 0.0% | 0.00% | – |
| Q2 2023 | $935 | -6.5% | 989 | 0.0% | 0.00% | – |
| Q1 2023 | $1,000 | +99900.0% | 989 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 989 | -58.4% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 2,377 | +52.2% | 0.00% | – |
| Q2 2022 | $4,000 | -71.4% | 1,562 | -66.1% | 0.00% | – |
| Q1 2022 | $14,000 | -17.6% | 4,605 | +34.0% | 0.00% | – |
| Q4 2021 | $17,000 | -96.5% | 3,437 | -93.0% | 0.00% | – |
| Q2 2021 | $484,000 | -95.3% | 49,405 | -92.1% | 0.00% | -100.0% |
| Q1 2021 | $10,356,000 | – | 625,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $27,939,000 | 39.70% |
| RA Capital Management | 5,014,687 | $12,637,000 | 0.34% |
| Artal Group S.A. | 2,255,375 | $5,684,000 | 0.30% |
| Redmile Group, LLC | 1,608,089 | $4,052,000 | 0.16% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 242,978 | $612,000 | 0.15% |
| Orbimed Advisors | 1,584,845 | $3,994,000 | 0.07% |
| Baker Brothers Advisors | 2,591,366 | $6,530,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,776,744 | $4,477,000 | 0.02% |
| Woodline Partners LP | 233,180 | $588,000 | 0.01% |
| AXA S.A. | 567,310 | $1,429,811 | 0.00% |